0001209191-21-060063.txt : 20211008 0001209191-21-060063.hdr.sgml : 20211008 20211008171248 ACCESSION NUMBER: 0001209191-21-060063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211006 FILED AS OF DATE: 20211008 DATE AS OF CHANGE: 20211008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lasky Laurence CENTRAL INDEX KEY: 0001553357 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39866 FILM NUMBER: 211316009 MAIL ADDRESS: STREET 1: C/O COLUMN GROUP LP STREET 2: 1700 OWENS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc. CENTRAL INDEX KEY: 0001828522 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 853306396 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET, 51ST FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 2157319450 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET, 51ST FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Locust Walk Acquisition Corp. DATE OF NAME CHANGE: 20201015 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-06 0 0001828522 eFFECTOR Therapeutics, Inc. EFTR 0001553357 Lasky Laurence C/O EFFECTOR THERAPEUTICS, INC. 11120 ROSELLE ST SUITE A SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 11.36 2021-10-06 4 A 0 40000 0.00 A 2031-10-05 Common Stock 40000 40000 D The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on August 25, 2021, subject to the Reporting Person's continued service with the Issuer through each vesting date. /s/ Michael Byrnes, Attorney-in-Fact for Laurence Lasky 2021-10-08